ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659,675 | -11.7% | 817,574 | 0.0% | 0.01% | -28.6% |
| Q2 2023 | $1,880,420 | -24.1% | 817,574 | 0.0% | 0.01% | -22.2% |
| Q1 2023 | $2,477,249 | +129939.3% | 817,574 | 0.0% | 0.01% | +28.6% |
| Q4 2022 | $1,905 | -99.9% | 817,574 | -56.9% | 0.01% | -50.0% |
| Q3 2022 | $3,620,000 | -37.0% | 1,895,161 | -10.7% | 0.01% | -33.3% |
| Q2 2022 | $5,749,000 | -9.1% | 2,121,406 | 0.0% | 0.02% | +16.7% |
| Q1 2022 | $6,322,000 | +1776.0% | 2,121,406 | +2347.7% | 0.02% | +1700.0% |
| Q4 2021 | $337,000 | +524.1% | 86,669 | +385.5% | 0.00% | – |
| Q2 2021 | $54,000 | -61.2% | 17,851 | -59.8% | 0.00% | -100.0% |
| Q3 2020 | $139,000 | -44.2% | 44,362 | -63.0% | 0.00% | -50.0% |
| Q2 2019 | $249,000 | – | 119,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,510,223 | $19,727,000 | 1.35% |
| Foresite Capital Management IV, LLC | 804,446 | $2,880,000 | 1.04% |
| EcoR1 Capital, LLC | 2,172,883 | $7,779,000 | 0.72% |
| DAFNA Capital Management LLC | 246,900 | $884,000 | 0.38% |
| BAILARD, INC. | 228,000 | $816,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,415 | $6,320,000 | 0.05% |
| Seelaus Asset Management LLC | 14,300 | $51,000 | 0.05% |
| Hudson Bay Capital Management LP | 650,000 | $2,327,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,040,900 | $14,466,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 71,560 | $256,000 | 0.01% |